{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:02:30Z","timestamp":1757703750623},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T00:00:00Z","timestamp":1480464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T00:00:00Z","timestamp":1480464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Nutr"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/ejcn.2016.246","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T11:04:03Z","timestamp":1480503843000},"page":"267-273","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Homocysteine-reducing B vitamins and ischemic heart disease: a separate-sample Mendelian randomization analysis"],"prefix":"10.1038","volume":"71","author":[{"given":"J V","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C M","family":"Schooling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,30]]},"reference":[{"key":"BFejcn2016246_CR1","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nrcardio.2015.82","volume":"12","author":"M Ezzati","year":"2015","unstructured":"Ezzati M, Obermeyer Z, Tzoulaki I, Mayosi BM, Elliott P, Leon DA . Contributions of risk factors and medical care to cardiovascular mortality trends. Nat Rev Cardiol 2015; 12: 508\u2013530.","journal-title":"Nat Rev Cardiol"},{"key":"BFejcn2016246_CR2","doi-asserted-by":"publisher","first-page":"e61495","DOI":"10.1371\/journal.pone.0061495","volume":"8","author":"IO Wong","year":"2013","unstructured":"Wong IO, Cowling BJ, Leung GM, Schooling CM . Age-period-cohort projections of ischaemic heart disease mortality by socio-economic position in a rapidly transitioning Chinese population. PLoS One 2013; 8: e61495.","journal-title":"PLoS One"},{"key":"BFejcn2016246_CR3","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","volume":"288","author":"Homocysteine Studies Collaboration","year":"2002","unstructured":"Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002; 288: 2015\u20132022.","journal-title":"JAMA"},{"key":"BFejcn2016246_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.5551\/jat.2196","volume":"16","author":"JT Real","year":"2009","unstructured":"Real JT, Martinez-Hervas S, Garcia-Garcia AB, Chaves FJ, Civera M, Ascaso JF et al. Association of C677T polymorphism in MTHFR gene, high homocysteine and low HDL cholesterol plasma values in heterozygous familial hypercholesterolemia. J Atheroscler Thromb 2009; 16: 815\u2013820.","journal-title":"J Atheroscler Thromb"},{"key":"BFejcn2016246_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jdiacomp.2003.12.003","volume":"19","author":"DA de Luis","year":"2005","unstructured":"de Luis DA, Fernandez N, Arranz ML, Aller R, Izaola O, Romero E . Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2. J Diabetes Complications 2005; 19: 42\u201346.","journal-title":"J Diabetes Complications"},{"key":"BFejcn2016246_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0009-8981(03)00082-2","volume":"332","author":"B Vanizor Kural","year":"2003","unstructured":"Vanizor Kural B, Orem A, Cimsit G, Uydu HA, Yandi YE, Alver A . Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. Clin Chim Acta 2003; 332: 23\u201330.","journal-title":"Clin Chim Acta"},{"key":"BFejcn2016246_CR7","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ejim.2012.07.004","volume":"23","author":"HT Yang","year":"2012","unstructured":"Yang HT, Lee M, Hong KS, Ovbiagele B, Saver JL . Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials. Eur J Intern Med 2012; 23: 745\u2013754.","journal-title":"Eur J Intern Med"},{"key":"BFejcn2016246_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/1755-5922.12064","volume":"32","author":"B Debreceni","year":"2014","unstructured":"Debreceni B, Debreceni L . The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease. Cardiovasc Ther 2014; 32: 130\u2013138.","journal-title":"Cardiovasc Ther"},{"key":"BFejcn2016246_CR9","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.2010.840","volume":"303","author":"JM Armitage","year":"2010","unstructured":"Study of the Effectiveness of Additional Reductions in C Homocysteine Collaborative G Study of the Effectiveness of Additional Reductions in C, Armitage JM, Study of the Effectiveness of Additional Reductions in C, Bowman L, Study of the Effectiveness of Additional Reductions in C, Clarke RJ, Study of the Effectiveness of Additional Reductions in C, Wallendszus K et al. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 2010; 303: 2486\u20132494.","journal-title":"JAMA"},{"key":"BFejcn2016246_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00394-010-0119-6","volume":"50","author":"SB Rafnsson","year":"2011","unstructured":"Rafnsson SB, Saravanan P, Bhopal RS, Yajnik CS . Is a low blood level of vitamin B12 a cardiovascular and diabetes risk factor? A systematic review of cohort studies. Eur J Nutr 2011; 50: 97\u2013106.","journal-title":"Eur J Nutr"},{"key":"BFejcn2016246_CR11","unstructured":"National Institute of Health https:\/\/ods.od.nih.gov\/factsheets\/Folate-HealthProfessional\/."},{"key":"BFejcn2016246_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3746\/pnf.2014.19.4.247","volume":"19","author":"JH Choi","year":"2014","unstructured":"Choi JH, Yates Z, Veysey M, Heo YR, Lucock M . Contemporary issues surrounding folic Acid fortification initiatives. Prev Nutr Food Sci 2014; 19: 247\u2013260.","journal-title":"Prev Nutr Food Sci"},{"key":"BFejcn2016246_CR13","unstructured":"Scotland could add folic acid to flour. Available at http:\/\/www.bbc.com\/news\/uk-scotland-35377163."},{"key":"BFejcn2016246_CR14","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3181\/0703-MR-67","volume":"232","author":"F Watanabe","year":"2007","unstructured":"Watanabe F . Vitamin B12 sources and bioavailability. Exp Biol Med (Maywood) 2007; 232: 1266\u20131274.","journal-title":"Exp Biol Med (Maywood)"},{"key":"BFejcn2016246_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.pbiomolbio.2015.03.007","volume":"118","author":"KR Shorter","year":"2015","unstructured":"Shorter KR, Felder MR, Vrana PB . Consequences of dietary methyl donor supplements: Is more always better? Prog Biophys Mol Biol 2015; 118: 14\u201320.","journal-title":"Prog Biophys Mol Biol"},{"key":"BFejcn2016246_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10545-010-9150-2","volume":"34","author":"R Carmel","year":"2011","unstructured":"Carmel R . Mandatory fortification of the food supply with cobalamin: an idea whose time has not yet come. J Inherit Metab Dis 2011; 34: 67\u201373.","journal-title":"J Inherit Metab Dis"},{"key":"BFejcn2016246_CR17","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1177\/15648265100311S104","volume":"31","author":"LH Allen","year":"2010","unstructured":"Allen LH, Rosenberg IH, Oakley GP, Omenn GS . Considering the case for vitamin B12 fortification of flour. Food Nutr Bull 2010; 31: S36\u2013S46.","journal-title":"Food Nutr Bull"},{"key":"BFejcn2016246_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1001\/jama.279.5.359","volume":"279","author":"EB Rimm","year":"1998","unstructured":"Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998; 279: 359\u2013364.","journal-title":"JAMA"},{"key":"BFejcn2016246_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/07315724.2008.10719684","volume":"27","author":"J Ishihara","year":"2008","unstructured":"Ishihara J, Iso H, Inoue M, Iwasaki M, Okada K, Kita Y et al. Intake of folate, vitamin B6 and vitamin B12 and the risk of CHD: the Japan Public Health Center-Based Prospective Study Cohort I. J Am Coll Nutr 2008; 27: 127\u2013136.","journal-title":"J Am Coll Nutr"},{"key":"BFejcn2016246_CR20","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1161\/01.CIR.103.22.2674","volume":"103","author":"S Voutilainen","year":"2001","unstructured":"Voutilainen S, Rissanen TH, Virtanen J, Lakka TA, Salonen JT . Kuopio Ischemic Heart Disease Risk Factor S. Low dietary folate intake is associated with an excess incidence of acute coronary events: The Kuopio Ischemic Heart Disease Risk Factor Study. Circulation 2001; 103: 2674\u20132680.","journal-title":"Circulation"},{"key":"BFejcn2016246_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1475-2891-9-31","volume":"9","author":"A Semmler","year":"2010","unstructured":"Semmler A, Moskau S, Grigull A, Farmand S, Klockgether T, Smulders Y et al. Plasma folate levels are associated with the lipoprotein profile: a retrospective database analysis. Nutr J 2010; 9: 31.","journal-title":"Nutr J"},{"key":"BFejcn2016246_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1023\/A:1019559328424","volume":"33","author":"S Ziakka","year":"2001","unstructured":"Ziakka S, Rammos G, Kountouris S, Doulgerakis C, Karakasis P, Kourvelou C et al. The effect of vitamin B6 and folate supplements on plasma homocysteine and serum lipids levels in patients on regular hemodialysis. Int Urol Nephrol 2001; 33: 559\u2013562.","journal-title":"Int Urol Nephrol"},{"key":"BFejcn2016246_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0021-9150(89)90200-1","volume":"75","author":"AJ Olszewski","year":"1989","unstructured":"Olszewski AJ, Szostak WB, Bialkowska M, Rudnicki S, McCully KS . Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis. Atherosclerosis 1989; 75: 1\u20136.","journal-title":"Atherosclerosis"},{"key":"BFejcn2016246_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jjcc.2012.11.009","volume":"61","author":"N Mahalle","year":"2013","unstructured":"Mahalle N, Kulkarni MV, Garg MK, Naik SS . Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease. J Cardiol 2013; 61: 289\u2013294.","journal-title":"J Cardiol"},{"key":"BFejcn2016246_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12933-014-0129-4","volume":"13","author":"A Adaikalakoteswari","year":"2014","unstructured":"Adaikalakoteswari A, Jayashri R, Sukumar N, Venkataraman H, Pradeepa R, Gokulakrishnan K et al. Vitamin B12 deficiency is associated with adverse lipid profile in Europeans and Indians with type 2 diabetes. Cardiovasc Diabetol 2014; 13: 129.","journal-title":"Cardiovasc Diabetol"},{"key":"BFejcn2016246_CR26","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G . Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008; 27: 1133\u20131163.","journal-title":"Stat Med"},{"key":"BFejcn2016246_CR27","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJMoa060900","volume":"354","author":"E Lonn","year":"2006","unstructured":"Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006; 354: 1567\u20131577.","journal-title":"N Engl J Med"},{"key":"BFejcn2016246_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jama.291.5.565","volume":"291","author":"JF Toole","year":"2004","unstructured":"Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004; 291: 565\u2013575.","journal-title":"JAMA"},{"key":"BFejcn2016246_CR29","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","volume":"299","author":"CM Albert","year":"2008","unstructured":"Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 2008; 299: 2027\u20132036.","journal-title":"JAMA"},{"key":"BFejcn2016246_CR30","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1097\/HJH.0000000000000647","volume":"33","author":"SC van Dijk","year":"2015","unstructured":"van Dijk SC, Enneman AW, Swart KM, van Wijngaarden JP, Ham AC, Brouwer-Brolsma EM et al. Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial. J Hypertens 2015; 33: 1897\u20131906. discussion 906.","journal-title":"J Hypertens"},{"key":"BFejcn2016246_CR31","doi-asserted-by":"crossref","unstructured":"Marti-Carvajal AJ, Sola I, Lathyris D, Salanti G . Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 2009 CD006612.","DOI":"10.1002\/14651858.CD006612.pub2"},{"key":"BFejcn2016246_CR32","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/mnfr.201400033","volume":"58","author":"Z Asemi","year":"2014","unstructured":"Asemi Z, Karamali M, Esmaillzadeh A . Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Mol Nutr Food Res 2014; 58: 1465\u20131473.","journal-title":"Mol Nutr Food Res"},{"key":"BFejcn2016246_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000045664","volume":"85","author":"D McGregor","year":"2000","unstructured":"McGregor D, Shand B, Lynn K . A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease. Nephron 2000; 85: 215\u2013220.","journal-title":"Nephron"},{"key":"BFejcn2016246_CR34","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1210\/jc.2004-1954","volume":"90","author":"P Villa","year":"2005","unstructured":"Villa P, Perri C, Suriano R, Cucinelli F, Panunzi S, Ranieri M et al. L-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism. J Clin Endocrinol Metab 2005; 90: 4622\u20134629.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFejcn2016246_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00394-014-0729-5","volume":"54","author":"L Wang","year":"2015","unstructured":"Wang L, Li H, Zhou Y, Jin L, Liu J . Low-dose B vitamins supplementation ameliorates cardiovascular risk: a double-blind randomized controlled trial in healthy Chinese elderly. Eur J Nutr 2015; 54: 455\u2013464.","journal-title":"Eur J Nutr"},{"key":"BFejcn2016246_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/0004563212473279","volume":"50","author":"CF Hughes","year":"2013","unstructured":"Hughes CF, Ward M, Hoey L, McNulty H . Vitamin B12 and ageing: current issues and interaction with folate. Ann Clin Biochem 2013; 50: 315\u2013329.","journal-title":"Ann Clin Biochem"},{"key":"BFejcn2016246_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ahj.2013.03.018","volume":"166","author":"BM Everett","year":"2013","unstructured":"Everett BM, Pradhan AD, Solomon DH, Paynter N, Macfadyen J, Zaharris E et al. Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis. Am Heart J 2013; 166: 199\u2013207 e15.","journal-title":"Am Heart J"},{"key":"BFejcn2016246_CR38","first-page":"174","volume":"124","author":"PM Ridker","year":"2013","unstructured":"Ridker PM . Closing the loop on inflammation and atherothrombosis: why perform the cirt and cantos trials? Trans Am Clin Climatol Assoc 2013; 124: 174\u2013190.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"BFejcn2016246_CR39","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3945\/ajcn.112.044545","volume":"98","author":"JB van Meurs","year":"2013","unstructured":"van Meurs JB, Pare G, Schwartz SM, Hazra A, Tanaka T, Vermeulen SH et al. Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease. Am J Clin Nutr 2013; 98: 668\u2013676.","journal-title":"Am J Clin Nutr"},{"key":"BFejcn2016246_CR40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ajhg.2009.02.011","volume":"84","author":"T Tanaka","year":"2009","unstructured":"Tanaka T, Scheet P, Giusti B, Bandinelli S, Piras MG, Usala G et al. Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am J Hum Genet 2009; 84: 477\u2013482.","journal-title":"Am J Hum Genet"},{"key":"BFejcn2016246_CR41","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1093\/hmg\/ddp428","volume":"18","author":"A Hazra","year":"2009","unstructured":"Hazra A, Kraft P, Lazarus R, Chen C, Chanock SJ, Jacques P et al. Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. Hum Mol Genet 2009; 18: 4677\u20134687.","journal-title":"Hum Mol Genet"},{"key":"BFejcn2016246_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng.2480","volume":"45","author":"CAD Consortium","year":"2013","unstructured":"Consortium CAD, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 2013; 45: 25\u201333.","journal-title":"Nat Genet"},{"key":"BFejcn2016246_CR43","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ng.784","volume":"43","author":"H Schunkert","year":"2011","unstructured":"Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, Holm H et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011; 43: 333\u2013338.","journal-title":"Nat Genet"},{"key":"BFejcn2016246_CR44","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","volume":"45","author":"C Global Lipids Genetics","year":"2013","unstructured":"Global Lipids Genetics C, Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S et al. Discovery and refinement of loci associated with lipid levels. Nat Genet 2013; 45: 1274\u20131283.","journal-title":"Nat Genet"},{"key":"BFejcn2016246_CR45","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/ng.3396","volume":"47","author":"M Nikpay","year":"2015","unstructured":"Nikpay M, Goel A, Won HH, Hall LM, Willenborg C, Kanoni S et al. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet 2015; 47: 1121\u20131130.","journal-title":"Nat Genet"},{"key":"BFejcn2016246_CR46","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","volume":"30","author":"S Burgess","year":"2015","unstructured":"Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG . Consortium E-I. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol 2015; 30: 543\u2013552.","journal-title":"Eur J Epidemiol"},{"key":"BFejcn2016246_CR47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.2517-6161.1954.tb00159.x","volume":"16","author":"EC Fieller","year":"1954","unstructured":"Fieller EC . Some problems in interval estimation. J R Stat Soc Series B Stat Methodol 1954; 16: 175\u2013185.","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"BFejcn2016246_CR48","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol 2016; 40: 304\u2013314.","journal-title":"Genet Epidemiol"},{"key":"BFejcn2016246_CR49","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/ng.3097","volume":"46","author":"AR Wood","year":"2014","unstructured":"Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet 2014; 46: 1173\u20131186.","journal-title":"Nat Genet"},{"key":"BFejcn2016246_CR50","doi-asserted-by":"publisher","first-page":"e51954","DOI":"10.1371\/journal.pone.0051954","volume":"7","author":"AG Comuzzie","year":"2012","unstructured":"Comuzzie AG, Cole SA, Laston SL, Voruganti VS, Haack K, Gibbs RA et al. Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population. PLoS ONE 2012; 7: e51954.","journal-title":"PLoS ONE"},{"key":"BFejcn2016246_CR51","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05911","volume":"447","author":"Wellcome Trust Case Control C","year":"2007","unstructured":"Wellcome Trust Case Control C. Genome-wide association study of 14000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661\u2013678.","journal-title":"Nature"},{"key":"BFejcn2016246_CR52","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1093\/hmg\/ddt032","volume":"22","author":"AY Chu","year":"2013","unstructured":"Chu AY, Workalemahu T, Paynter NP, Rose LM, Giulianini F, Tanaka T et al. Novel locus including FGF21 is associated with dietary macronutrient intake. Hum Mol Genet 2013; 22: 1895\u20131902.","journal-title":"Hum Mol Genet"},{"key":"BFejcn2016246_CR53","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/CIRCGENETICS.108.829804","volume":"2","author":"G Pare","year":"2009","unstructured":"Pare G, Chasman DI, Parker AN, Zee RR, Malarstig A, Seedorf U et al. Novel associations of CPS1, MUT, NOX4, and DPEP1 with plasma homocysteine in a healthy population: a genome-wide evaluation of 13 974 participants in the Women's Genome Health Study. Circ Cardiovasc Genet 2009; 2: 142\u2013150.","journal-title":"Circ Cardiovasc Genet"},{"key":"BFejcn2016246_CR54","doi-asserted-by":"publisher","first-page":"6072","DOI":"10.1002\/sim.3427","volume":"27","author":"JP Higgins","year":"2008","unstructured":"Higgins JP, White IR, Anzures-Cabrera J . Meta-analysis of skewed data: combining results reported on log-transformed or raw scales. Stat Med 2008; 27: 6072\u20136092.","journal-title":"Stat Med"},{"key":"BFejcn2016246_CR55","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1373\/clinchem.2006.083881","volume":"53","author":"RY Zee","year":"2007","unstructured":"Zee RY, Mora S, Cheng S, Erlich HA, Lindpaintner K, Rifai N et al. Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. Clin Chem 2007; 53: 845\u2013851.","journal-title":"Clin Chem"},{"key":"BFejcn2016246_CR56","doi-asserted-by":"publisher","first-page":"387","DOI":"10.7326\/0003-4819-131-5-199909070-00010","volume":"131","author":"I Graham","year":"1999","unstructured":"Graham I . Homocysteine in health and disease. Ann Intern Med 1999; 131: 387\u2013388.","journal-title":"Ann Intern Med"},{"key":"BFejcn2016246_CR57","doi-asserted-by":"publisher","first-page":"1731S","DOI":"10.1093\/jn\/136.6.1731S","volume":"136","author":"H Refsum","year":"2006","unstructured":"Refsum H, Nurk E, Smith AD, Ueland PM, Gjesdal CG, Bjelland I et al. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr 2006; 136: 1731S\u20131740SS.","journal-title":"J Nutr"},{"key":"BFejcn2016246_CR58","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/07435800009066165","volume":"26","author":"SN Badri","year":"2000","unstructured":"Badri SN, Vanithakumari G, Malini T . Studies on methotrexate effects on testicular steroidogenesis in rats. Endocr Res 2000; 26: 247\u2013262.","journal-title":"Endocr Res"},{"key":"BFejcn2016246_CR59","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/BF01366958","volume":"122","author":"P Sagaster","year":"1996","unstructured":"Sagaster P, Flamm J, Micksche M, Fritz E, Donner G, Ludwig H . Maximal androgen blockade in combination with methotrexate for treatment of metastatic prostate cancer. J Cancer Res Clin Oncol 1996; 122: 171\u2013176.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFejcn2016246_CR60","first-page":"412","volume":"8","author":"LB Korman","year":"1989","unstructured":"Korman LB . Treatment of prostate cancer. Clin Pharm 1989; 8: 412\u2013424.","journal-title":"Clin Pharm"},{"key":"BFejcn2016246_CR61","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/01.CIR.100.4.335","volume":"100","author":"MC Verhaar","year":"1999","unstructured":"Verhaar MC, Wever RM, Kastelein JJ, van Loon D, Milstien S, Koomans HA et al. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial. Circulation 1999; 100: 335\u2013338.","journal-title":"Circulation"},{"key":"BFejcn2016246_CR62","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1371\/journal.pmed.0020135","volume":"2","author":"MR Olthof","year":"2005","unstructured":"Olthof MR, van Vliet T, Verhoef P, Zock PL, Katan MB . Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans. PLoS Med 2005; 2: e135.","journal-title":"PLoS Med"},{"key":"BFejcn2016246_CR63","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/clc.4960251105","volume":"25","author":"S Hirsch","year":"2002","unstructured":"Hirsch S, Pia De la Maza M, Yanez P, Glasinovic A, Petermann M, Barrera G et al. Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation. Clin Cardiol 2002; 25: 495\u2013501.","journal-title":"Clin Cardiol"},{"key":"BFejcn2016246_CR64","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/ije\/dyt110","volume":"42","author":"G Freeman","year":"2013","unstructured":"Freeman G, Cowling BJ, Schooling CM . Power and sample size calculations for Mendelian randomization studies using one genetic instrument. Int J Epidemiol 2013; 42: 1157\u20131163.","journal-title":"Int J Epidemiol"},{"key":"BFejcn2016246_CR65","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/aje\/kws344","volume":"177","author":"CM Schooling","year":"2013","unstructured":"Schooling CM, Freeman G, Cowling BJ . Mendelian randomization and estimation of treatment efficacy for chronic diseases. Am J Epidemiol 2013; 177: 1128\u20131133.","journal-title":"Am J Epidemiol"},{"key":"BFejcn2016246_CR66","first-page":"316","volume":"2","author":"SM Collin","year":"2011","unstructured":"Collin SM, Metcalfe C, Palmer TM, Refsum H, Lewis SJ, Smith GD et al. The causal roles of vitamin B(12) and transcobalamin in prostate cancer: can Mendelian randomization analysis provide definitive answers? Int J Mol Epidemiol Genet 2011; 2: 316\u2013327.","journal-title":"Int J Mol Epidemiol Genet"},{"key":"BFejcn2016246_CR67","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/ije\/dys223","volume":"42","author":"KJ Rothman","year":"2013","unstructured":"Rothman KJ, Gallacher JE, Hatch EE . Why representativeness should be avoided. Int J Epidemiol 2013; 42: 1012\u20131014.","journal-title":"Int J Epidemiol"},{"key":"BFejcn2016246_CR68","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1001\/jama.2015.2274","volume":"313","author":"Y Huo","year":"2015","unstructured":"Huo Y, Li J, Qin X, Huang Y, Wang X, Gottesman RF et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA 2015; 313: 1325\u20131335.","journal-title":"JAMA"},{"key":"BFejcn2016246_CR69","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ehb.2013.12.002","volume":"13","author":"AE Taylor","year":"2014","unstructured":"Taylor AE, Davies NM, Ware JJ, Vanderweele T, Smith GD, Munafo MR . Mendelian randomization in health research: Using appropriate genetic variants and avoiding biased estimates. Econ Hum Biol 2014; 13: 99\u2013106.","journal-title":"Econ Hum Biol"},{"key":"BFejcn2016246_CR70","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/ije\/dyt023","volume":"42","author":"EJ Tchetgen Tchetgen","year":"2013","unstructured":"Tchetgen Tchetgen EJ, Walter S, Glymour MM . Commentary: building an evidence base for mendelian randomization studies: assessing the validity and strength of proposed genetic instrumental variables. Int J Epidemiol 2013; 42: 328\u2013331.","journal-title":"Int J Epidemiol"},{"key":"BFejcn2016246_CR71","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/0039-128X(90)90058-J","volume":"55","author":"MF Kalin","year":"1990","unstructured":"Kalin MF, Zumoff B . Sex hormones and coronary disease: a review of the clinical studies. Steroids 1990; 55: 330\u2013352.","journal-title":"Steroids"}],"container-title":["European Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ejcn2016246.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ejcn2016246","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ejcn2016246.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T22:04:50Z","timestamp":1718921090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejcn2016246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,30]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFejcn2016246"],"URL":"https:\/\/doi.org\/10.1038\/ejcn.2016.246","relation":{},"ISSN":["0954-3007","1476-5640"],"issn-type":[{"value":"0954-3007","type":"print"},{"value":"1476-5640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,30]]},"assertion":[{"value":"26 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}